In the melanoma-bearing human immune system (HIS) mouse model, we observed that a combination of ngTASO and anti-PD-1 antibody additionally delay the tumor growth, which is mediated by the potentiation of T cell-mediated antitumor immunity such as activation and increased infiltration of CTLs. This evidence concerns the gene PDCD1 and neoplasm.